WIN 57273, a new fluoroquinolone with enhanced in vitro activity versus gram-positive pathogens.

doi:10.1128/AAC.34.7.1376

Back to search

Article

WIN 57273, a new fluoroquinolone with enhanced in vitro activity versus gram-positive pathogens.

Antimicrobial agents and chemotherapy - 1 Jul 1990

Kaatz G W, Seo S M

Abstract excerpt

WIN 57273 is a new fluoroquinolone with excellent in vitro activity versus gram-positive pathogens, including methicillin-susceptible and -resistant Staphylococcus aureus and Staphylococcus epidermidis and gentamicin-susceptible and -resistant Enterococcus faecalis. We compared the microdilution...

Topics

4-Quinolones
Anti-Infective Agents
Drug Resistance, Microbial
Enterococcus faecalis
Fluoroquinolones
Gram-Positive Bacteria
Microbial Sensitivity Tests
Mutation
Quinolones
Staphylococcus aureus
Staphylococcus epidermidis
beta-Lactamases

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.